International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2019 - Volume 23, Number 1
View All Articles in Issue

Page(s): 53

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr, PhD, RPh, formulation, ketoprofen, nonsteroidal anti-inflammatory drugs, NSAID, analgesic, analgesia, pain, inflammation, anti-inflammatory

Related Categories: FORMULATIONS, PAIN MANAGEMENT, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Utilization of Compounded Medications in an Oral Medicine Practice Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel	Mar/Apr 2016 Pg. 155-158
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Ketoprofen 20% Topical Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 452
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Managing Pain with Transdermal Ketoprofen Williams KaCee D	May/Jun 2010 Pg. 204-206
Naproxen 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 145
Ketoprofen 100-mg/5-mL Mouth Rinse Allen Loyd V Jr	Jan/Feb 2010 Pg. 68
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Mar/Apr 2019 Pg. 150
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 514
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 520
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 157
Return to Top